GMPs On Tour: FDA Briefs EU, Japan To Avoid Trade Issues From New Rules
FDA is explaining its new good manufacturing practice regulations to regulatory officials in other countries to minimize disruptions in trade once they are implemented
You may also be interested in...
FDA expects to release a draft on improving the agency's good manufacturing practices management systems by Dec. 1
FDA and the European Medicines Evaluation Agency will conduct a joint assessment of the approaches used by the two agencies in the 1998 cohort of new molecular entity reviews.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011